PhRMA submission to HHS on blueprint to lower drug prices and reduce out-of-pocket costs
By Holly Campbell | July 16, 2018
Today, PhRMA submitted comprehensive comments to the Department of Health and Human Services (HHS) request for information (RFI), HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs....
Read More
Event next week: Supporting the next generation of lifesaving medicines
By Andrew Powaleny | July 12, 2018
The remarkable scientific advancements in recent history are due, in part, to thoughtful public policies that promote innovation and discovery. These policies support the tireless efforts of more...
Read More
GAO again recommends improvements to 340B program
By Nicole Longo | July 11, 2018
Over the years, the non-partisan Government Accountability Office (GAO) has reviewed various aspects of the 340B program, finding areas for improvement and providing recommendations. The latest...
Read More
How ICER’s assessment of a new class of migraine treatments fails patients
By Lauren Neves | July 10, 2018
Over 50 million Americans suffer from migraine and the majority of patients affected by this often debilitating disease are between 25 and 55 years old – the time they are most productive in their...
Read More
New data show patients’ out-of-pocket costs are rising faster than their insurers’ costs
By Holly Campbell | July 9, 2018
Newly released data from the Kaiser Family Foundation show out-of-pocket costs for patients with employer-sponsored health insurance rose faster than the costs paid by their insurers between 2006...
Read More
Pass-through rebates do not violate non-interference clause but they do increase savings for seniors
By Jim C. Stansel | July 2, 2018
For more than a decade, Medicare Part D has successfully provided seniors with comprehensive prescription drug coverage. Key to its success is a unique, market-based structure of private-sector...
Read More
Guest post: Excellent care for LGBTQ patients requires cultural humility and specific medical knowledge
By Guest Contributor | June 28, 2018
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Medicare Part D cliff ahead
By Juliet Johnson | June 21, 2018
Medicare Part D has been providing seniors with access to prescription drug coverage that meets their needs for more than a decade. Today, more than 42 million people are enrolled in Part D and 90...
Read More
Aspen Spotlight Health: Discussing the forefront of innovation
By Katie Koziara | June 21, 2018
For the second year in a row, PhRMA is proud to participate in Aspen’s Spotlight Health Conference. As the opening session of Aspen Ideas Festival, Spotlight Health welcomes over 1,500 experts and...
Read More
Patients with a deductible have seen their out-of-pocket costs for brand medicines increase 50 percent since 2014
By Holly Campbell | June 20, 2018
Spending on medicines is growing at the slowest rate in years, but according to a new IQVIA Institute for Human Data Science article, at the pharmacy, commercially insured patients with a...
Read More
Medicare Monday (100)
340B Spotlight (36)
Cost & Consequence (0)
